Netherlands (Kingdom of the) vs San Marino: Proportion of the target population who received
Netherlands (Kingdom of the)
81.0%
in 2024
San Marino
81.0%
in 2024
Netherlands (Kingdom of the) rank
114th
San Marino rank
114th
Proportion of the target population who received over time
- Netherlands (Kingdom of the)
- San Marino
How they compare
Netherlands (Kingdom of the) currently reports 81.0% against 81.0% in San Marino, a difference of 0.0%.
The two have swapped places 5 times across 22 shared years of data; in 2003 it was Netherlands (Kingdom of the) ahead.
Netherlands (Kingdom of the) ranks 114th and San Marino ranks 114th of 193 countries.
Netherlands (Kingdom of the) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Netherlands (Kingdom of the) | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.1% | 93.4% | 0.7% | Netherlands (Kingdom of the) |
| 2010s | 91.5% | 85.0% | 6.5% | Netherlands (Kingdom of the) |
| 2020s | 85.2% | 81.0% | 4.2% | Netherlands (Kingdom of the) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Netherlands (Kingdom of the) or San Marino?
- Netherlands (Kingdom of the), at 81.0% against 81.0% in San Marino as of 2024.
- What is the difference in proportion of the target population who received between Netherlands (Kingdom of the) and San Marino?
- 0.0%, with Netherlands (Kingdom of the) ahead.
- How many years of comparable data are there for Netherlands (Kingdom of the) and San Marino?
- 22 years are reported by both, from 2003 to 2024.
- How do Netherlands (Kingdom of the) and San Marino rank globally for proportion of the target population who received?
- Netherlands (Kingdom of the) ranks 114th and San Marino ranks 114th of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.